Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Evofem Biosciences (EVFM) stock

Learn how to easily invest in Evofem Biosciences stock.

Evofem Biosciences, Inc
NASDAQ: EVFM - USD
BIOTECHNOLOGY
$0.89
-$0.0005 (-0.06%)

Evofem Biosciences, Inc is a biotechnology business based in the US. Evofem Biosciences shares (EVFM) are listed on the NASDAQ and all prices are listed in US Dollars. Evofem Biosciences employs 147 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Evofem Biosciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EVFM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Evofem Biosciences stock price (NASDAQ: EVFM)

Use our graph to track the performance of EVFM stocks over time.

Evofem Biosciences shares at a glance

Information last updated 2021-07-22.
Latest market close$0.86
52-week range$0.75 - $5.53
50-day moving average $1.06
200-day moving average $2.01
Wall St. target price$6.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.01

Buy Evofem Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Evofem Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Evofem Biosciences price performance over time

Historical closes compared with the close of $0.86 from 2021-05-28

1 week (2021-07-14) N/A
1 month (2021-06-25) -26.50%
3 months (2021-04-21) N/A
6 months (2021-01-21) N/A
1 year (2020-07-21) N/A
2 years (2019-07-21) N/A
3 years (2018-07-21) N/A
5 years (2016-07-21) N/A

Evofem Biosciences financials

Revenue TTM $1.6 million
Gross profit TTM $78,000
Return on assets TTM -147.96%
Return on equity TTM -1675.9%
Profit margin 0%
Book value $0.02
Market capitalisation $141.8 million

TTM: trailing 12 months

Shorting Evofem Biosciences shares

There are currently 28.7 million Evofem Biosciences shares held short by investors – that's known as Evofem Biosciences's "short interest". This figure is 15.3% up from 24.9 million last month.

There are a few different ways that this level of interest in shorting Evofem Biosciences shares can be evaluated.

Evofem Biosciences's "short interest ratio" (SIR)

Evofem Biosciences's "short interest ratio" (SIR) is the quantity of Evofem Biosciences shares currently shorted divided by the average quantity of Evofem Biosciences shares traded daily (recently around 18.3 million). Evofem Biosciences's SIR currently stands at 1.57. In other words for every 100,000 Evofem Biosciences shares traded daily on the market, roughly 1570 shares are currently held short.

However Evofem Biosciences's short interest can also be evaluated against the total number of Evofem Biosciences shares, or, against the total number of tradable Evofem Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Evofem Biosciences's short interest could be expressed as 0.19% of the outstanding shares (for every 100,000 Evofem Biosciences shares in existence, roughly 190 shares are currently held short) or 0.3039% of the tradable shares (for every 100,000 tradable Evofem Biosciences shares, roughly 304 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Evofem Biosciences.

Find out more about how you can short Evofem Biosciences stock.

Evofem Biosciences share dividends

We're not expecting Evofem Biosciences to pay a dividend over the next 12 months.

Have Evofem Biosciences's shares ever split?

Evofem Biosciences's shares were split on a 1:6 basis on 17 January 2018. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evofem Biosciences shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Evofem Biosciences shares which in turn could have impacted Evofem Biosciences's share price.

Evofem Biosciences share price volatility

Over the last 12 months, Evofem Biosciences's shares have ranged in value from as little as $0.751 up to $5.53. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evofem Biosciences's is -0.4696. This would suggest that Evofem Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Evofem Biosciences has bucked the trend.

Evofem Biosciences overview

Evofem Biosciences, Inc. , a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc.

Frequently asked questions

What percentage of Evofem Biosciences is owned by insiders or institutions?
Currently 1.397% of Evofem Biosciences shares are held by insiders and 35.157% by institutions.
How many people work for Evofem Biosciences?
Latest data suggests 147 work at Evofem Biosciences.
When does the fiscal year end for Evofem Biosciences?
Evofem Biosciences's fiscal year ends in December.
Where is Evofem Biosciences based?
Evofem Biosciences's address is: 12400 High Bluff Drive, San Diego, CA, United States, 92130
What is Evofem Biosciences's ISIN number?
Evofem Biosciences's international securities identification number is: US30048L1044
What is Evofem Biosciences's CUSIP number?
Evofem Biosciences's Committee on Uniform Securities Identification Procedures number is: 30048L104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site